Amanote Research

Amanote Research

    RegisterSign In

Liposomes Modified by Carbohydrate Ligands Can Target B Cells for the Treatment of B-Cell Lymphomas

Expert Review of Vaccines - United Kingdom
doi 10.1586/erv.10.121
Full Text
Open PDF
Abstract

Available in full text

Categories
Molecular MedicineDrug DiscoveryImmunologyPharmacology
Date

November 1, 2010

Authors
Geert-Jan Boons
Publisher

Informa UK Limited


Related search

Emerging Treatment Options for B-Cell Lymphomas

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2015English

Venetoclax Synergizes With Radiotherapy for Treatment of B-Cell Lymphomas

Cancer Research
Cancer ResearchOncology
2017English

Pretargeted Radioimmunotherapy for B-Cell Lymphomas

Clinical Cancer Research
Cancer ResearchOncology
2007English

Double-Hit B-Cell Lymphomas

Blood
BiochemistryImmunologyCell BiologyHematology
2011English

Identification of Pax5 as a Target of MTA1 in B-Cell Lymphomas

Cancer Research
Cancer ResearchOncology
2007English

Ruxolitinib Treatment and Risk of B‐cell Lymphomas in Myeloproliferative Neoplasms

American Journal of Hematology
Hematology
2019English

Cell Cycle Deregulation in B-Cell Lymphomas

Blood
BiochemistryImmunologyCell BiologyHematology
2003English

CD10 Expression in Peripheral T-Cell Lymphomas Complicated by a Proliferation of Large B-Cells

Modern Pathology
Forensic MedicinePathology
2006English

Lenalidomide in Diffuse Large B-Cell Lymphomas

Advances in Hematology
Hematology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy